Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Replication Protein A Availability during DNA Replication Stress Is a Major Determinant of Cisplatin Resistance in Ovarian Cancer Cells

Bélanger, François, Fortier, Emile, Dubé, Maxime, Lemay, Jean-François, Buisson, Rémi, Masson, Jean-Yves, Elsherbiny, Abdelhamid, Costantino, Santiago, Carmona, Euridice, Mes-Masson, Anne-Marie, Wurtele, Hugo, Drobetsky, Elliot · 2018 · Cancer Research

Published version of a preprint

Abstract

Intrinsic and acquired resistance to cisplatin remains a primary hurdle to treatment of high-grade serous ovarian cancer (HGSOC). Cisplatin selectively kills tumor cells by inducing DNA crosslinks that block replicative DNA polymerases. Single-stranded DNA (ssDNA) generated at resulting stalled replication forks (RF) is bound and protected by heterotrimeric replication protein A (RPA), which then serves as a platform for recruitment and activation of replication stress response factors. Cells deficient in this response are characterized by extensive ssDNA formation and excessive RPA recruitment that exhausts the available pool of RPA, which (i) inhibits RPA-dependent processes such as nucleotide excision repair (NER) and (ii) causes catastrophic failure of blocked RF. Here, we investigated the influence of RPA availability on chemosensitivity using a panel of human HGSOC cell lines. Our data revealed a striking correlation among these cell lines between cisplatin sensitivity and the inability to efficiently repair DNA via NER, specifically during S phase. Such defects in NER were attributable to RPA exhaustion arising from aberrant activation of DNA replication origins during replication stress. Reduced RPA availability promoted Mre11-dependent degradation of nascent DNA at stalled RF in cell lines exhibiting elevated sensitivity to cisplatin. Strikingly, defective S-phase NER, RF instability, and cisplatin sensitivity could all be rescued by ectopic overexpression of RPA. Taken together, our findings indicate that RPA exhaustion represents a major determinant of cisplatin sensitivity in HGSOC cell lines. Significance: The influence of replication protein A exhaustion on cisplatin sensitivity harbors important implications toward improving therapy of various cancers that initially respond to platinum-based agents but later relapse due to intrinsic or acquired drug resistance. Cancer Res; 78(19); 5561–73. ©2018 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-18-0618

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 50 · Cited by 58

Metadata

Authors
Bélanger, F., Fortier, E., Dubé, M., Lemay, J.-F., Buisson, R., Masson, J.-Y., Elsherbiny, A., Costantino, S., Carmona, E., Mes-Masson, A.-M., Wurtele, H., & Drobetsky, E.
Affiliations
  • Hôpital Maisonneuve-Rosemont (CA)
  • 1Centre de Recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Canada.
  • Université Laval (CA)
  • 5Centre de Recherche du Centre Hospitalier de l'Université de Montréal, and Institut du Cancer de Montréal, Montréal, Canada.
  • 2Programme de Biologie Moléculaire, Université de Montréal, Montréal, Canada.
Venue
Cancer Research
Published
2018-10-01
Volume
78
Issue
19
Pages
5561-5573
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2885846020
Cited by
58
References
50
Citations by year
2026: 1 · 2025: 5 · 2024: 7 · 2023: 8 · 2022: 6 · 2021: 9 · 2020: 14 · 2019: 6 · 2018: 2
FWCI
2.76
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Gouvernement du Canada | Canadian Institutes of Health Research (CIHR) (364096)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
  • Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords
replication protein A, cisplatin resistance, high-grade serous ovarian cancer, replication stress, single-stranded DNA, nucleotide excision repair, MRE11, origin of replication, platinum-based chemotherapy, drug resistance
MeSH terms
Cisplatin, DNA Damage, DNA Repair, DNA Replication, DNA, Single-Stranded, Female, Humans, Ovarian Neoplasms, Drug Resistance, Neoplasm, RNA, Small Interfering, Cell Line, Tumor, Replication Protein A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Replication Protein A Availability during DNA Replication Stress Is a Major Determinant of Cisplatin Resistance in Ovarian Cancer Cells. https://app.cochat.ai/papers/10.1158/0008-5472.can-18-0618
The paper
Bélanger, F., Fortier, E., Dubé, M., Lemay, J.-F., Buisson, R., Masson, J.-Y., Elsherbiny, A., Costantino, S., Carmona, E., Mes-Masson, A.-M., Wurtele, H., & Drobetsky, E. (2018). Replication Protein A Availability during DNA Replication Stress Is a Major Determinant of Cisplatin Resistance in Ovarian Cancer Cells. Cancer Research. https://doi.org/10.1158/0008-5472.can-18-0618

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.